B. Joseph Guglielmo, PharmD
Dean, School of Pharmacy
Clinical Pharmacy
School of Pharmacy

He was named dean of the UCSF School of Pharmacy in 2012 and holds the Troy C. Daniels Distinguished Professorship in Pharmaceutical Science.

As dean, Guglielmo oversees the activities and progress of three departments; a campus organized research unit; and a dean’s office charged with School administration and finance, strategic planning, communications, academic affairs, and the development and delivery of a doctor of pharmacy (PharmD) degree program. His leadership as dean actively supports the distinguishing UCSF concept of One UCSF and upholds the institution’s PRIDE values. During his tenure as dean, the School of Pharmacy has remained the top recipient among pharmacy schools nationwide of research dollars from the National Institutes of Health (NIH), and its PharmD degree program has remained among the top-rated such programs in the nation. Guglielmo initiated a transformation of the PharmD degree program, which welcomed its first class in 2018. The program’s foundation of scientific thinking evolves from the distinctive scientific mindset of the faculty, and the faculty’s drive to seek and apply new knowledge across research, education, and patient care. Guglielmo is widely known as an advocate for therapeutics-related research, from basic science to health policy research. As chair of the School's Department of Clinical Pharmacy, Guglielmo oversaw a 40 percent increase in the Department of Clinical Pharmacy’s faculty research funding. He created the department-run Medication Outcomes Center in 2007 to improve medication use at UCSF Health and beyond. In the late 1980s he developed the UCSF Medical Center Antimicrobial Stewardship Program to ensure the safe, effective use of antimicrobials, focusing upon decreasing antimicrobial resistance. The program was one of the earliest programs of its kind in the United States. As patients seek new and cost-effective health care with increasingly complicated disease states and medications, Guglielmo advocates for research on new ways for pharmacists to care for patients, especially in the community. He also supports strong relationships among clinical scientists and their upstream basic and translational scientist colleagues, as demonstrated through his own collaborations. Guglielmo has been actively involved in the UCSF Clinical and Translational Science Institute (CTSI) from its inception and during its renewal; he has also served as past associate director of the CTSI Mentor Development Program. His personal research agenda involves the safe, effective, and appropriate use of antimicrobials, as well as the pharmacoepidemiology and pharmacokinetics of anti-infective agents. He is the author of numerous peer-reviewed papers, book chapters, and abstracts, the majority related to anti-infective agents. He believes that the most important clinical research is shaped through the researcher’s own clinical experiences. Together with his administrative, research, and teaching responsibilities, he continues to be active as an infectious diseases pharmacist supporting the UCSF Medical Center Antimicrobial Stewardship Program and serving on the Infectious Diseases Consult Service team. These experiences continue to provide the background for important hypothesis-centered research on the safe, effective use of antimicrobials.

Beyond the hospital, Guglielmo developed clinical pharmacy services for UCSF HIV/AIDS programs, specifically for the HIV Women's Program and the Men of Color Program.

Guglielmo has taught doctor of pharmacy students, pharmacy residents and fellows, medical students and residents, and infectious diseases fellows for decades, and he has mentored infectious diseases specialty pharmacist residents and fellows continuously since 1986. He has also mentored a number of international scholars, including Fogarty fellows. He is the recipient of many teaching awards, including the UCSF Lifetime Achievement in Mentoring Award, Resident Preceptor of the Year Awards, UCSF School of Pharmacy Long Teaching Awards, and UCSF Academic Senate Distinction in Teaching Award. He is a fellow of the American College Clinical Pharmacy and the Infectious Diseases Society of America.

Guglielmo earned a PharmD from the University of Southern California in 1978 and completed a PharmD residency at UCSF in 1979.

• Incidence and risk factors for vancomycin nephrotoxicity in acutely ill pediatric patients
  J Pharm Technol 2018 Woldu H, Guglielmo BJ
• Incidence and Risk Factors for Vancomycin Nephrotoxicity in Acutely Ill Pediatric Patients.
  The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 2017 Woldu H, Guglielmo BJ
• Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain.
  Parasitology research 2015 Roy SL, Atkins JT, Gennuso R, Kofos D, Sriram RR, Dorlo TP, Hayes T, Qvarnstrom Y, Kucerova Z, Guglielmo BJ, Visvesvara GS
• Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012.
  JAMA internal medicine 2014 Cheng CM, Shin J, Guglielmo BJ
• Pediatric medication administration errors and workflow following implementation of a bar code medication administration system.
  Journal for healthcare quality : official publication of the National Association for Healthcare Quality 2014 Hardmeier A, Tsourounis C, Moore M, Abbott WE, Guglielmo BJ
• Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort.
  Pharmacotherapy 2014 Gahbauer AM, Gonzales ML, Guglielmo BJ
• Ethanol locks in the prevention and treatment of catheter-related bloodstream infections.
  The Annals of pharmacotherapy 2014 Tan M, Lau J, Guglielmo BJ
• Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
  The Pediatric infectious disease journal 2013 Frymoyer A, Guglielmo BJ, Hersh AL
• Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.
  Journal of perinatology : official journal of the California Perinatal Association 2013 Frymoyer A, Lee S, Bonifacio SL, Meng L, Lucas SS, Guglielmo BJ, Sun Y, Verotta D
• Co-administration of a commonly used Zimbabwean herbal treatment (African potato) does not alter the pharmacokinetics of lopinavir/ritonavir.
  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2013 Gwaza L, Aweeka F, Greenblatt R, Lizak P, Huang L, Guglielmo BJ
• Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.
  Pharmacotherapy 2013 Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo BJ
• Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital.
  Hospital pharmacy 2013 Burrell C, Tsourounis C, Quan D, Jue V, Tam E, Guglielmo BJ
• The colchicine debacle.
  JAMA internal medicine 2013 Guglielmo BJ
• Improved antiretroviral refill adherence in HIV-focused community pharmacies.
  Journal of the American Pharmacists Association : JAPhA 2012 Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo BJ
• Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy.
  AIDS patient care and STDs 2012 Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ
• Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring.
  International journal of clinical pharmacy 2012 Swartling M, Gupta R, Dudas V, Guglielmo BJ
• Boxed warning inconsistencies between drug information resources and the prescribing information.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2011 Cheng CM, Fu C, Guglielmo BJ, Auerbach AD
• Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.
  Pharmacotherapy 2011 Frymoyer A, Guglielmo BJ, Wilson SD, Scarpace SB, Benet LZ, Hersh AL
• A critical appraisal of and recommendations for faculty development.
  American journal of pharmaceutical education 2011 Guglielmo BJ, Edwards DJ, Franks AS, Naughton CA, Schonder KS, Stamm PL, Thornton P, Popovich NG
• Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
  International journal of clinical pharmacy 2011 Meyer-Massetti C, Vaerini S, Rätz Bravo AE, Meier CR, Guglielmo BJ
• Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
  Archives of internal medicine 2011 Cheng C, Guglielmo BJ
• Systematic review of medication safety assessment methods.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2011 Meyer-Massetti C, Cheng CM, Schwappach DL, Paulsen L, Ide B, Meier CR, Guglielmo BJ
• National estimates and predictors of prescription medication sample use in the United States, 1999-2005.
  Journal of the American Pharmacists Association : JAPhA 2010 Macdougall C, Udkow T, Guglielmo BJ, Vittinghoff E, Martin J
• Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients.
  American journal of infection control 2010 Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS
• A prescription for improved chronic disease management: have community pharmacists function at the top of their training: comment on "Engaging physicians and pharmacists in providing smoking cessation counseling".
  Archives of internal medicine 2010 Guglielmo BJ
• Coverage of FDA medication boxed warnings in commonly used drug information resources.
  Archives of internal medicine 2010 Cheng CM, Guglielmo BJ, Maselli J, Auerbach AD
• Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010 Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ
• The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?
  Journal of hospital medicine 2010 Meyer-Massetti C, Cheng CM, Sharpe BA, Meier CR, Guglielmo BJ
• Development of daptomycin-susceptible, methicillin-resistant Staphylococcus aureus pneumonia during high-dose daptomycin therapy.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009 Koplowicz YB, Schwartz BS, Guglielmo BJ
• Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
  Transplant infectious disease : an official journal of the Transplantation Society 2009 Martin T, Sharma M, Damon L, Kaplan L, Guglielmo BJ, Working M, O'Malley R, Hwang J, Linker C
• Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program.
  Clinical and translational science 2009 Feldman MD, Huang L, Guglielmo BJ, Jordan R, Kahn J, Creasman JM, Wiener-Kronish JP, Lee KA, Tehrani A, Yaffe K, Brown JS
• Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.
  The Pediatric infectious disease journal 2009 Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ
• Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures.
  The Annals of pharmacotherapy 2008 Yang K, Zhuo H, Guglielmo BJ, Wiener-Kronish J
• Five years later: re-examining the financial burden of boosting with Norvir.
  AIDS (London, England) 2008 Marquez C, Guglielmo BJ, Klausner JD
• Antimicrobial stewardship programs: interventions and associated outcomes.
  Expert review of anti-infective therapy 2008 Patel D, Lawson W, Guglielmo BJ
• Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance.
  Cerebrovascular diseases (Basel, Switzerland) 2008 Frenzel T, Lee CZ, Kim H, Quinnine NJ, Hashimoto T, Lawton MT, Guglielmo BJ, McCulloch CE, Young WL
• Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding?
  The Annals of pharmacotherapy 2008 Schwartz BS, Ngo PD, Guglielmo BJ
• Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients.
  Journal of the American Pharmacists Association : JAPhA 2007 Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ
• Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.
  The Annals of pharmacotherapy 2007 Yang K, Guglielmo BJ
• Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
  BMC infectious diseases 2007 Riedel A, Choe L, Inciardi J, Yuen C, Martin T, Guglielmo BJ
• In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4.
  Journal of herbal pharmacotherapy 2007 Nicandro JP, Tsourounis C, Frassetto L, Guglielmo BJ
• Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein.
  Drug metabolism and disposition: the biological fate of chemicals 2006 Huang Y, Okochi H, May BC, Legname G, Prusiner SB, Benet LZ, Guglielmo BJ, Lin ET
• In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
  The Journal of eukaryotic microbiology 2006 Schuster FL, Guglielmo BJ, Visvesvara GS
• Pharmacological advances in the treatment of invasive candidiasis.
  Expert review of anti-infective therapy 2006 Deck DH, Guglielmo BJ
• Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation.
  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2006 Lee CZ, Yao JS, Huang Y, Zhai W, Liu W, Guglielmo BJ, Lin E, Yang GY, Young WL
• Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections.
  Pharmacotherapy 2006 Mendez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo BJ
• Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci.
  Joint Commission journal on quality and patient safety 2005 Guglielmo BJ, Dudas V, Maewal I, Young R, Hilts A, Villmann M, Gibbs L, Gropper M, Jacobs R
• Antimicrobial drug prescribing for pneumonia in ambulatory care.
  Emerging infectious diseases 2005 MacDougall C, Guglielmo BJ, Maselli J, Gonzales R
• Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia.
  Pharmacotherapy 2005 Chang NN, Murray CK, Houck PM, Bratzler DW, Greenway C, Guglielmo BJ
• Pharmacokinetics of quinacrine in the treatment of prion disease.
  BMC infectious diseases 2004 Yung L, Huang Y, Lessard P, Legname G, Lin ET, Baldwin M, Prusiner SB, Ryou C, Guglielmo BJ
• Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
  The Annals of pharmacotherapy 2004 Killgore KM, March KL, Guglielmo BJ
• Pharmacokinetics of valaciclovir.
  The Journal of antimicrobial chemotherapy 2004 MacDougall C, Guglielmo BJ
• Compliance in two medical centers with criteria for use of caspofungin and lipid-based amphotericin B.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2004 Bower AN, Tang HM, Guglielmo BJ
• Impact of emerging technologies on medication errors and adverse drug events.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2003 Oren E, Shaffer ER, Guglielmo BJ
• Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor.
  Antimicrobial agents and chemotherapy 2003 Phan DD, Chin-Hong P, Lin ET, Anderle P, Sadee W, Guglielmo BJ
• Pharmacy-based intervention to reduce antibiotic use for acute bronchitis.
  The Annals of pharmacotherapy 2003 Hickman DE, Stebbins MR, Hanak JR, Guglielmo BJ
• Characteristics of antimicrobial overrides associated with automated dispensing machines.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002 Oren E, Griffiths LP, Guglielmo BJ
• Patient education for H pylori: who benefits?
  The Western journal of medicine 2002 Yang K, Guglielmo BJ
• Antimicrobial therapy of gram-negative bacteremia at two university-affiliated medical centers.
  The American journal of medicine 2002 Graff LR, Franklin KK, Witt L, Cohen N, Jacobs RA, Tompkins L, Guglielmo BJ
• Restricted access to automated dispensing machines for surgical antimicrobial prophylaxis.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2001 Botwin KJ, Chan J, Jacobs R, Guglielmo BJ
• Impact of an intravenous fluconazole restriction policy on patient outcomes.
  The Annals of pharmacotherapy 2001 Burkiewicz JS, Kostiuk KA, Jacobs RA, Guglielmo BJ
• Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals.
  The Annals of pharmacotherapy 2000 Dudas V, Hopefl A, Jacobs R, Guglielmo BJ
• Ceftriaxone therapy for staphylococcal osteomyelitis: a review.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000 Guglielmo BJ, Luber AD, Paletta D, Jacobs RA
• Prevention of adverse events in hospitalized patients using an antimicrobial review program.
  The Western journal of medicine 1999 Guglielmo BJ, Luber AD, Corelli RL, Flaherty JF, Jacobs RA
• Risk factors for amphotericin B-induced nephrotoxicity.
  The Journal of antimicrobial chemotherapy 1999 Luber AD, Maa L, Lam M, Guglielmo BJ
• Use of antimicrobial agents in patients with cardiovascular disease.
  The Journal of cardiovascular nursing 1999 Guglielmo BJ
• Lipid formulations of amphotericin B: clinical efficacy and toxicities.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998 Wong-Beringer A, Jacobs RA, Guglielmo BJ
• Pharmacokinetics and pharmacodynamics of ceftizoxime in abscess fluid.
  The Journal of antimicrobial chemotherapy 1997 Guglielmo BJ, Kostiuk KA, Pons VG
• Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury.
  The Journal of antimicrobial chemotherapy 1996 Hashimoto S, Wolfe E, Guglielmo B, Shanks R, Sundelof J, Pittet JF, Thomas E, Wiener-Kronish J
• Hypothermia following the intravenous administration of amphotericin B.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996 Barlows TG, Luber AD, Jacobs RA, Guglielmo BJ
• Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis.
  The Annals of pharmacotherapy 1996 Tsourounis C, Guglielmo BJ
• Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1996 Guglielmo BJ, Jacobs RA
• Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients.
  The Journal of antimicrobial chemotherapy 1996 Guglielmo BJ, Quan LA, Stulbarg MS
• Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci.
  The Journal of infectious diseases 1996 Luber AD, Jacobs RA, Jordan M, Guglielmo BJ
• Practical strategies for the appropriate use of antimicrobials.
  Pharmacy world & science : PWS 1995 Guglielmo BJ
• Influence of timing of antibiotic administration on tissue concentrations during surgery.
  American journal of surgery 1995 Wong-Beringer A, Corelli RL, Schrock TR, Guglielmo BJ
• Sterility of unit dose syringes of filgrastim and sargramostim.
  American journal of hospital pharmacy 1994 Singh RF, Corelli RL, Guglielmo BJ
• Penetration of fluconazole into abscess fluid.
  The Journal of antimicrobial chemotherapy 1994 Kostiuk KA, Pons VG, Guglielmo BJ
• Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
  Bone marrow transplantation 1994 Guglielmo BJ, Wong-Beringer A, Linker CA
• Systemic absorption of oral fluconazole after gastrointestinal resection.
  The Journal of antimicrobial chemotherapy 1994 Joe LA, Jacobs RA, Guglielmo BJ
• The new macrolides. Azithromycin and clarithromycin.
  The Western journal of medicine 1994 Kanatani MS, Guglielmo BJ
• Nosocomial funguria: resultant morbidity and therapeutic intervention.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993 Wong-Beringer A, Jacobs RA, Guglielmo BJ
• Ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis: a randomized, prospective, blinded clinical study.
  Neurosurgery 1993 Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB
• Comment; ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis.
  Neurosurgery 1993 Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB
• Home antibiotic therapy for streptococcal endocarditis: a call for a controlled trial.
  The American journal of medicine 1993 Colford JM, Corelli RL, Ganz JW, Guglielmo BJ, Jacobs RA
• Treatment of funguria.
  JAMA 1992 Wong-Beringer A, Jacobs RA, Guglielmo BJ
• Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
  Clinical pharmacy 1992 Barriere SL, Guglielmo BJ
• Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review.
  DICP : the annals of pharmacotherapy 1991 Corelli RL, Guglielmo BJ, Kapusnik-Uner JE, McMaster JR, Greenblatt RM
• Iodine toxicity secondary to continuous povidone-iodine mediastinal irrigation in dogs.
  The Journal of surgical research 1990 Glick PL, Guglielmo BJ, Winter ME, Finkbeiner W, Turley K
• Antibiotic prophylaxis in cesarean section.
  DICP : the annals of pharmacotherapy 1990 Glick M, Guglielmo BJ
• What is the clinical role of aerosolized ribavirin?
  DICP : the annals of pharmacotherapy 1990 Hebert MF, Guglielmo BJ
• Antimicrobial therapy. Cost-benefit considerations.
  Drugs 1989 Guglielmo BJ, Brooks GF
• Experience with selective reporting of susceptibility to antimicrobial agents.
  American journal of hospital pharmacy 1989 Brodowy BA, Guglielmo BJ, York MK, Herfindal ET, Brooks GF
• Microbiology and antibiotics in infectious abdominal emergencies.
  Emergency medicine clinics of North America 1989 Tam J, Guglielmo BJ
• Pharmacist-managed drug therapy in California hospitals.
  American journal of hospital pharmacy 1989 Guglielmo BJ, Schweigert BF, Kishi DT
• Effect of surgical blood loss and volume replacement on antibiotic pharmacokinetics.
  The Annals of thoracic surgery 1989 Sue D, Salazar TA, Turley K, Guglielmo BJ
• Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis.
  The Journal of infectious diseases 1989 Oliva SL, Guglielmo BJ, Jacobs R, Pons VG
• The exposure of health care workers to ribavirin aerosol.
  JAMA 1989 Guglielmo BJ, Jacobs RA, Locksley RM
• Altered pharmacokinetics of antibiotics during vascular surgery.
  American journal of surgery 1989 Guglielmo BJ, Salazar TA, Rodondi LC, Carver M, Goldstone J, Stoney RJ
• Amphotericin B concentration in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis.
  Clinical pharmacy 1989 Dugoni BM, Guglielmo BJ, Hollander H
• Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens.
  Antimicrobial agents and chemotherapy 1988 Flaherty JF, Rodondi LC, Guglielmo BJ, Fleishaker JC, Townsend RJ, Gambertoglio JG
• Comparison of antibiotic activities by using serum bactericidal activity over time.
  Antimicrobial agents and chemotherapy 1988 Guglielmo BJ, Rodondi LC
• Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers.
  Antimicrobial agents and chemotherapy 1988 Lam YW, Duroux MH, Gambertoglio JG, Barriere SL, Guglielmo BJ
• Assessing Exposures of Health-care Personnel to Aerosols of Ribavirin-California
  Morbidity and Mortality Weekly Reports 1988 R.J. Harrison, J. Bellows, D. Rempel, L. Rudolph, K. Kizer, A. Jin, B.J. Guglielmo
• Comparison of Antibiotic Activity Using Serum Bactericidal Activity Over Time
  Antimicrob. Agents Chemother 1988 B.J. Guglielmo and L.C. Rodondi
• Effect of Protein Binding on Serum Bactericidal Activities of Ceftazidime and Cefoperazone in Healthy Volunteers
  Antimicrob. Agents Chemother9. Effect of Protein Binding on Serum Bactericidal Activities of Ceftazidime and Cefoperazone in Healthy Volunteers 1988 Y.W.F. Lam, M.H. Duroux, J.G. Gambertoglio, S.L. Barriere, and B.J. Guglielmo
• Severe Hypersensitivity Reaction Upon Rechallenge With Trimethoprim-sulfamethoxazole in a Patient With AIDS
  Drug Intell. Clin. Pharm. 22, 43-45 (1988). 1988 P.A. Arnold, B.J. Guglielmo, and H. Hollander
• Severe hypersensitivity reaction upon rechallenge with trimethoprim-sulfamethoxazole in a patient with AIDS.
  Drug intelligence & clinical pharmacy 1988 Arnold PA, Guglielmo BJ, Hollander H
• We are Concerned About Ribavirin Exposure
  Resp. Care 1988 M.J. Mahlmeister, B.J. Guglielmo, and R. Harrison
• Pharmacokinetics of cefoperazone and tobramycin alone and in combination.
  Antimicrobial agents and chemotherapy 1987 Guglielmo BJ, Flaherty JF, Woods TM, LaFollette G, Gambertoglio JG
• Pharmacokinetics of Cefoperazone and Tobramycin Alone and in Combination
  Antimicrob. Ag. Chemother 1987 B.J. Guglielmo, J.F. Flaherty, T.M. Woods, G. LaFollette, and J.G. Gambertoglio
• Comparative pharmacokinetics of low- and high-dose ticarcillin.
  Antimicrobial agents and chemotherapy 1986 Guglielmo BJ, Flaherty JF, Batman R, Barriere SL, Gambertoglio JG
• Comparative Pharmacokinetics of Low- and High-Dose Ticarcillin
  Antimicrob. Ag. Chemother 1986 B.J. Guglielmo, J.F. Flaherty, R. Batman, S.L. Barriere, and J.G. Gambertoglio
• Iodine toxicity in a patient treated by continuous povidone-iodine mediastinal irrigation.
  The Annals of thoracic surgery 1985 Glick PL, Guglielmo BJ, Tranbaugh RF, Turley K
• Iodine Toxicity in a Patient Treated by Continuous Povidone-Iodine Mediastinal Irrigation
  Ann. Thorac. Surg 1985 P.L. Glick, B.J. Guglielmo, R.F. Tranbaugh, and K. Turley
• Antibiotic Prophylaxis in Surgical Procedures. A Critical Analysis of the Literature
  Arch. Surg 1983 B.J. Guglielmo, D.C. Hohn, P.J. Koo, T.K. Hunt, R.C. Sweet, and J.E. Conte
• Excessive Potassium Depletion with Metolazone and Furosemide
  Clin. Pharm 1983 W.A. Kehoe and B.J. Guglielmo
• Prolonged Diarrhea Secondary to Methyldopa Therapy
  Drug Intell. Clin. Pharm 1983 B.D. Quart and B.J. Guglielmo
• Theophylline elixir, moxalactam, and a disulfiram reaction.
  Annals of internal medicine 1982 Brown KR, Guglielmo BJ, Pons VG, Jacobs RA
• Theophylline Elixir, Moxalactam, and a Disulfiram Reaction
  Ann. Int. Med. 1982 K.R. Brown, B.J. Guglielmo, V.G. Pons, and R.A. Jacobs